U.S. Dialysis Market Share Expected to Gain US$ 129.75 BN, at a 4.7% CAGR by 2028

Rise in incidences of kidney diseases and prevalence of lifestyle and chronic diseases led to adoption of different dialysis treatments. This made medical device and equipment manufacturers to launch new products that would improve effectiveness and performance.

These products are aimed at improving patient experiences. Many market players have been launching new programs to provide care to patients at home. These strategic initiatives are launched at various regions. This help market players in raising their market share by enhancing their presence in different regions and widening the customer base. The demand for advanced dialysis equipment and processes will increase in coming years. According to the report published by Allied Market Research, the global dialysis market is projected to reach $129.75 billion by 2028.

Download Sample Report at:

https://www.alliedmarketresearch.com/request-sample/374

Following are some of the activities taking place across the world.

Medical devices and equipment manufacturers launched new systems for carrying out dialysis. Nipro Medical Corporation (Nipro) launched the SURDIAL DX Hemodialysis System in the U.S. market. The company developed this system to provide an effective dialysis treatment for patients. The patient-focused features have been developed by the company in collaboration with clinicians from across the world. These features provide optimal ergonomics and performance. The company aims to roll out the full scale commercial product in the U.S.

Rise in incidences of kidney diseases, surge in prevalence of lifestyle and chronic diseases, and issues related to kidney transplants drive the growth of the global dialysis market. However, complications in dialysis treatment and reimbursement policy concerns in developing countries hinder the market growth. On the contrary, shift in preference of patients for home hemodialysis and increase in market strategies by market players would open new opportunities in the future.

"Factors that drive the growth of the global dialysis market include rise in incidences of kidney diseases globally. Furthermore, issues related with kidney transplants and increase in occurrences of lifestyle and chronic diseases supplement the market growth. On the contrary, complications in dialysis treatment and concerns regarding reimbursements in emerging nations are likely to hinder the growth of the market. Conversely, change in preference of patients from in-center hemodialysis (ICHD) to home hemodialysis (HHD) and advancements in key alliances by pharmaceutical players such as acquisitions, dialysis product launches, and partnerships are expected to provide new opportunities for dialysis market expansion in the future".

Joe Dawson, the Executive VP of Nipro Medical Corporation, highlighted that the launch of the product is in line with the long-term strategic initiative of the company to become a comprehensive provider of hemodialysis solution. The company has been offering training certification and extensive services for healthcare professionals to operate the product. The launch of new products will enable healthcare facilities in offering solutions for different types of dialysis and improve the patient experience.

Along with the launch of new product, healthcare facilities have been trying to modernize the operations and equipment for dialysis. BION implemented various strategies to transform technical operations of dialysis. These strategies involve cost-effective and efficient methods to maintain dialysis equipment and carry out other operations. BION offers support for different dialysis care settings, including hospitals, outpatient treatment centers, skilled nursing facilities, and home therapies. The company launched a staff-assisted home hemodialysis dialysis program. This program is implemented within a nursing home in Philadelphia. This program will provide care for residents within their homes. In addition, the company made a team that will operate its technical department and provide cost-effective and value-added services for patients at home.

Inquire More About the Top Market Players Here:

https://www.alliedmarketresearch.com/purchase-enquiry/374

Covid-19 scenario:

• The rise in the number of Covid-19 patients increased the demand for dialysis in case of severe infection.
• However, the prolonged lockdown resulted in the supply chain disruption and shortage of raw materials.

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.